Portfolio

      
          Discovery
          Proof of Concept
          IND Enabling Studies
          Phase 1 Clinical Trial
          Indications
        
          Anti-Epcam PARs
           
          Solid Tumors Breast/Colon
        
          Anti-CD133 PARs
           
          Cancer Stem Cells
        
          Anti-CD19 PARs
           
          Leukemia/ Lymphoma
        
          Universal CAR T-cell
           
          Hybrid CAR/PAR